aabb 2017 annual meeting available on demand sessions by
play

AABB 2017 Annual Meeting Available On Demand Sessions By Day # GEN, - PowerPoint PPT Presentation

AABB 2017 Annual Meeting Available On Demand Sessions By Day # GEN, PHY, CN # FLP & CLP Session Session Day Date Session ID Session Title Credits Credits Saturday 7 Oct 17 0104 TC 80 Frozen Blood Products Are Safe and


  1. AABB 2017 Annual Meeting Available On ‐ Demand Sessions By Day # GEN, PHY, CN # FLP & CLP Session Session Day Date Session ID Session Title Credits Credits Saturday 7 ‐ Oct ‐ 17 0104 ‐ TC ‐ 80 Frozen Blood Products Are Safe and Effective 1.5 1.5 Saturday 7 ‐ Oct ‐ 17 0105 ‐ TC Expert Guidance on Dealing with Apheresis Procedures in Patients with Significant Co ‐ Morbidities 0.5 0 Saturday 7 ‐ Oct ‐ 17 0106 ‐ TC Grow It Yourself: Planting a Pre ‐ Operative Anemia Program at Your Institution 1.25 1.25 Saturday 7 ‐ Oct ‐ 17 0107 ‐ TC Hogwarts School of Antigens and Antibodies 1.25 1.25 Saturday 7 ‐ Oct ‐ 17 0108 ‐ TC Mass Casualty Events: Transfusion Service Perspective 1.5 1.5 Saturday 7 ‐ Oct ‐ 17 0109 ‐ QE Biorepositories 202: Ensuring Value through Quality Practices 1.25 1.25 Mind Your P's and Q's (and Don't Forget the I's and O's)! 1.25 1.25 Saturday 7 ‐ Oct ‐ 17 0110 ‐ QE Saturday 7 ‐ Oct ‐ 17 0111 ‐ LM 25 Years of Operations and Quality: Are We Partners? 0.25 0 Process Excellence: A Roadmap for Inventing Your Company’s Future 1.25 1.25 Saturday 7 ‐ Oct ‐ 17 0112 ‐ LM IDSA/AABB Special Joint Session: Donations with Unintended Consequences: A Multidisciplinary Saturday 7 ‐ Oct ‐ 17 0113 ‐ S 1.5 1.5 Approach to Reduce Blood, Cell, Tissue and Organ Donor ‐ Transmitted Infections Saturday 7 ‐ Oct ‐ 17 0114 ‐ S Blood Components Produced in Vitro from Stem Cell Sources 0.5 0 Saturday 7 ‐ Oct ‐ 17 0115 ‐ S Mechanisms Controlling B Cell Autoreactivity Against Red Cell Antigens 0.75 0 AABB/ISBT Joint Session: Men Who Have Sex with Men: Is Individual Risk Assessment on the Horizon? 1.5 1.5 Saturday 7 ‐ Oct ‐ 17 0117 ‐ TC “Observe One, Do One, Teach One”: Is It Enough for Teaching Apheresis Medicine? 1.5 1.5 Saturday 7 ‐ Oct ‐ 17 0118 ‐ QE Saturday 7 ‐ Oct ‐ 17 0119 ‐ QE Cellular Therapy Product Development and Licensure 1.25 1.25 Drones are Delivering Blood: Why Not for You? 0.25 0 Saturday 7 ‐ Oct ‐ 17 0120 ‐ LM Saturday 7 ‐ Oct ‐ 17 0121 ‐ TC Sally Frank Memorial Award and Lectureship 1.25 1.25 Laboratory Monitoring of FDA Approved Factor Concentrates: The Pros and Cons 1 1 Saturday 7 ‐ Oct ‐ 17 0122 ‐ TC Saturday 7 ‐ Oct ‐ 17 0123 ‐ TC Pre ‐ Hospital Blood Product Resuscitation in Patients with Life Threatening Hemorrhage 2.5 2.5 Teaching Problem Solving and Analytical Decision Making Skills 2.5 2.5 Saturday 7 ‐ Oct ‐ 17 0124 ‐ QE Cord Blood TNT − Thawing and Tes � ng 1.25 1.25 Saturday 7 ‐ Oct ‐ 17 0126 ‐ TC Teen Donors: Handle with Kid Gloves? 0.75 0 Saturday 7 ‐ Oct ‐ 17 0127 ‐ TC Saturday 7 ‐ Oct ‐ 17 0128 ‐ QE Developing Sustainable Transfusion Medicine Education Programs in Developing Countries 1.5 1.5 Saturday 7 ‐ Oct ‐ 17 0129 ‐ QE Information Technology Professional Certificate in Blood Banking: Program Development 1 1 Page 1 of 5

  2. AABB 2017 Annual Meeting Available On ‐ Demand Sessions By Day # GEN, PHY, CN # FLP & CLP Session Session Day Date Session ID Session Title Credits Credits National Blood Foundation Grant Recipients' Lecture and Luncheon 0.25 0 Saturday 7 ‐ Oct ‐ 17 0130 ‐ S Saturday 7 ‐ Oct ‐ 17 0131 ‐ TC Apheresis Luncheon: Quality Management in Apheresis 0.25 0 Armed Services Blood Program AABB Workshop: Leading and Transforming Transfusion Medicine Sunday 8 ‐ Oct ‐ 17 0125 ‐ LM 3 3 Around the World in Peacetime and at War Sunday 8 ‐ Oct ‐ 17 0201 ‐ S Emily Cooley and Tibor Greenwalt Memorial Awards and Lectureships 1 1 Sunday 8 ‐ Oct ‐ 17 0203 ‐ TC How to Make a Cellular Immunotherapy 1.25 1.25 Sunday 8 ‐ Oct ‐ 17 0204 ‐ TC When Cells Fall Apart − the Importance of Micropar � cles in Blood Products 1.25 1.25 The Best of the Transfusion News ‐ Question of the Day (Mobile ARS) 1 1 Sunday 8 ‐ Oct ‐ 17 0205 ‐ QE You Can Manage but Can You Lead? 1.25 1.25 Sunday 8 ‐ Oct ‐ 17 0207 ‐ LM Chief Technologist SIG (Mobile ARS) 1.25 1.25 Sunday 8 ‐ Oct ‐ 17 0208 ‐ TC Sunday 8 ‐ Oct ‐ 17 0209 ‐ QE SBB/BB Exam Review 3 3 Sunday 8 ‐ Oct ‐ 17 0211 ‐ S TTD I − What EID Agents Concern Us Today ‐ Focus on ZIKV 1.5 1.5 Sunday 8 ‐ Oct ‐ 17 0212 ‐ TC Don't Play "Hot Potato" with TTP: A 360 Degree Approach to TTP Patient Care (Mobile ARS) 1.5 1.5 Pediatric Transfusion Practice 1.5 1.5 Sunday 8 ‐ Oct ‐ 17 0213 ‐ TC Sunday 8 ‐ Oct ‐ 17 0214 ‐ TC Personalized and Precision Medicine Converge to Meet Rare Blood Needs 0.25 0 Pooled Human Platelet Lysate (pHPL) for Cell Therapies Manufacturing − an Ini � a � ve from the 0.75 0 Sunday 8 ‐ Oct ‐ 17 0215 ‐ TC AABB/ISCT Joint Working Group To Tell the Truth: Blood and HPCs − FDA Reportable or Not? (Mobile ARS) 1.5 1.5 Sunday 8 ‐ Oct ‐ 17 0216 ‐ QE Sunday 8 ‐ Oct ‐ 17 0217 ‐ TC Donor Hemovigilance: Case Studies and Innovations (Mobile ARS) 1.25 1.25 Sunday 8 ‐ Oct ‐ 17 0218 ‐ LM Empower Employees, Change a Culture and Realize Organizational Benefits 1 1 Sunday 8 ‐ Oct ‐ 17 0219 ‐ TC AABB/ASFA Joint Session: Pediatric Apheresis: ECP, Vascular Access and Neurological Diseases 1.5 1.5 Sunday 8 ‐ Oct ‐ 17 0220 ‐ TC AABB/TERMIS Joint Session 1 1 Sunday 8 ‐ Oct ‐ 17 0221 ‐ S Genetic Modification of Cellular Therapies: What's in the Toolbox? 1.25 1.25 New Concepts of the Pathophysiology, Treatment and Clinical Aspects of Transfusion Related Acute Sunday 8 ‐ Oct ‐ 17 0222 ‐ S 1.25 1.25 Lung Injury (TRALI) Page 2 of 5

  3. AABB 2017 Annual Meeting Available On ‐ Demand Sessions By Day # GEN, PHY, CN # FLP & CLP Session Session Day Date Session ID Session Title Credits Credits Sunday 8 ‐ Oct ‐ 17 0224 ‐ S TTD II − Pathogen Reduced Platelets: Implementa � on Considera � ons 1.25 1.25 Sunday 8 ‐ Oct ‐ 17 0225 ‐ TC Is That Really Transfusion Related? What Is the View of Our Clinical Colleagues? (Mobile ARS) 1.25 1.25 Precision Transfusion Medicine ‐ Master the Bleeding Disaster! (Mobile ARS) 1.25 1.25 Sunday 8 ‐ Oct ‐ 17 0226 ‐ TC How to Perform Non ‐ Adversarial Blood Utilization Review, Mentor Physicians about Better Patient Sunday 8 ‐ Oct ‐ 17 0227 ‐ QE 1.5 1.5 Blood Management, and Create Meaningful Physician Ongoing Professional Practice Evaluations (OPPE) Sunday 8 ‐ Oct ‐ 17 0228 ‐ QE Test Your Blood Bank Knowledge: 2017 Version (Mobile ARS) 1.25 1.25 What Does It Take to be a Blood Bank CEO 1.25 1.25 Sunday 8 ‐ Oct ‐ 17 0229 ‐ LM Implementation of FDA Draft Guidance for Bacterial Detection in Platelets: How to Choose the Best 1 1 Sunday 8 ‐ Oct ‐ 17 0230 ‐ TC Option for Your Hospital (Mobile ARS) Rebalanced Hemostasis in Cirrhosis − Restric � ve Blood Component Therapy (Mobile ARS) 1.5 1.5 Sunday 8 ‐ Oct ‐ 17 0231 ‐ TC Stump the Hemovigilance Experts (Mobile ARS) 1.5 1.5 Sunday 8 ‐ Oct ‐ 17 0232 ‐ TC Transgender Blood Donors: Perspectives on a Population (Mobile ARS) 1.75 1.75 Sunday 8 ‐ Oct ‐ 17 0233 ‐ TC Sunday 8 ‐ Oct ‐ 17 0234 ‐ QE Cleaning, Sanitization, and Disinfection Best Practices for Cellular Therapy Laboratories 1.5 1.5 Staffing to Workload 1 1 Sunday 8 ‐ Oct ‐ 17 0235 ‐ LM Sunday 8 ‐ Oct ‐ 17 0236 ‐ LM The Non ‐ Medical Things You Do as a Medical Director: Business Academy for Medical Directors 1.25 1.25 Cellular Therapies Sizzling Topics Luncheon ‐ Things Physicians and Patients Should Know Concerning 1.75 1.75 Sunday 8 ‐ Oct ‐ 17 0241 ‐ S Cell Therapies: Choosing Wisely New and Reliable Hematopoietic Stem Progenitor Cells Potency Assays? The Search for the Holy Grail 0.25 0 Monday 9 ‐ Oct ‐ 17 0301 ‐ TC Delivering the Message: Communication of Critical Values and Vital Results from Blood Bank to Bedside 1.25 1.25 Monday 9 ‐ Oct ‐ 17 0303 ‐ QE Monday 9 ‐ Oct ‐ 17 0304 ‐ QE The Flipped Classroom in Transfusion Education 1.5 1.5 Monday 9 ‐ Oct ‐ 17 0305 ‐ LM Availability and Safety of Blood Transfusion in Humanitarian Emergencies 1.25 1.25 Monday 9 ‐ Oct ‐ 17 0306 ‐ LM The Role of Transfusion Medicine in Enterprise Risk Management 1.25 1.25 Monday 9 ‐ Oct ‐ 17 0307 ‐ LM Hemphill ‐ Jordan Award 0.75 0 Monday 9 ‐ Oct ‐ 17 0308 ‐ S Auto ‐ and Allo ‐ Immune Mechanisms of Platelet Destruction and Their Clinical Sequelae 1.5 1.5 Hacking the RBC: Producing Designer RBCs for Novel Uses 0.75 0 Monday 9 ‐ Oct ‐ 17 0309 ‐ S Transfusion Related Immune Modulation: Fact or Fantasy 1.25 1.25 Monday 9 ‐ Oct ‐ 17 0310 ‐ S Page 3 of 5

Recommend


More recommend